BioSpace News Archive

FDA

Maxim Biomedical Inc. Receives EUA for New ClearDetect™ COVID-19 Antigen Home Test

On January 19, 2022 , Maxim Biomedical (MaximBio) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for their new ClearDetect™ COVID-19 Antigen Home Test ( ClearDetect™ ).

January 25, 2022
·
3 min read
Business

Nippon Shinyaku and Capricor Therapeutics Enter into an Exclusive Partnership for Commercialization and Distribution of CAP-1002 for the Treatment* of Duchenne Muscular Dystrophy in US

Nippon Shinyaku Co., Ltd. announced today that Nippon Shinyaku and Capricor Therapeutics (Headquarters: California, USA, CEO: Linda Marbán, NASDAQ: CAPR) have entered into an exclusive distribution agreement for CAP-1002 for the treatment* of Duchenne muscular dystrophy (DMD) in the territory of US.

January 25, 2022
·
5 min read
New Study Shows Males Can Naturally Increase Sperm Count By 167%, Semen Volume by 53% and Testosterone Levels by 17%

Cedars-Sinai Cardiologist Dr. David Filsoof has recently created a huge buzz in the medical community by sharing some extremely promising clinical studies for men that suffer from low testosterone and/or low fertility levels.

January 25, 2022
·
2 min read
Policy

Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has granted priority review of a supplemental new drug application for the use of Evrysdi® to treat pre-symptomatic babies under two months of age with spinal muscular atrophy.

January 25, 2022
·
10 min read
Business

Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology

Evotec SE announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell -based disease modelling for ophthalmologic disorders.

January 25, 2022
·
4 min read
Biotech Bay

Microba to Present Therapeutic Discovery Progress at Microbiome Movement – Drug Development Summit

Microba Life Sciences, a precision microbiome science company, will showcase its Therapeutic Platform and Discovery Platform for the identification of novel microbial signatures at annual Europe summit.

January 25, 2022
·
2 min read
Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Lifebit announces a long-term partnership where Lifebit’s technology, Lifebit CloudOS, will power a cloud-based Trusted Research Environment to serve as the scalable and secure data management and analysis platform for researchers at the National Institute for Health Research Cambridge Biomedical Research Centre.

January 25, 2022
·
3 min read
Business

West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced an exclusive supply and technology agreement with Corning Incorporated.

January 25, 2022
·
4 min read
Business

Johnson & Johnson Reports Q4 and Full-Year 2021 Results

2021 Fourth-Quarter Sales of $24.8 Billion reflecting growth of 10.4%, operational sales growth of 11.6% and adjusted operational sales growth of 12.3%.

January 25, 2022
·
29 min read
BioMidwest

Ocuphire to Host Virtual Investor R&D Day on January 31st

Ocuphire Pharma, Inc. today announced that it will host a virtual investor R&D Day on Monday, January 31, 2022 from 10:00am to 12:15pm ET.

January 25, 2022
·
7 min read